Introduction: Electronic portal imaging devices (EPIDs) are extensively used for dosimetric information of pre-treatment field verification and in-vivo dosimetry for Intensity Modulated Radiotherapy (IMRT) 1, 2 . In the present work, we have implemented the newly developed portal dosimetry software using independent dose prediction algorithm EPIDose TM and evaluated this new tool for the pretreatment IMRT plan QA of whole pelvis with simultaneous integrated boost (WP-SIB-IMRT) of prostate cases by comparing with routine 2D array detector system (MapCHECK TM ) .
Materials and methods:
All measurements were performed using 6 MV X-ray beam at CLINAC 600C linear accelerator (Varian Associates, Palo Alto CA, USA) equipped with Millennium120 multileaf collimator (MLC). we have compared the measured doses between the two detectors (EPIDose and MapCHECK) and TPS calculated ones for every split field. In the current investigation  value distribution for 104 split fields were analyzed using -distributions. In particular, for each split field the following  distribution parameters were determined: mean  value,   value, defined as the previous mean  value + 1.5 SD and Percentage of points with <1, <1.5 and >2.
Results:
We have investigated 104 split fields using -distributions in terms of predefined  frequency parameters. In a sample of comparison of measured dose maps using EPIDose with TPS calculated doses, the mean  values are found to be 0.42 (SD:0.06) and 0.44 (SD: 0.06) for the EPIDose and MapCHECK, respectively. The average   for EPIDose and MapCHECK are found as 0.51 (SD:0.06) and 0.53 (SD: 0.07), respectively. Furthermore, the percentage of points with <1, <1.5 and >2 are 97.4%, 99.3% and 0.56%, respectively for EPIDose and 96.4%, 99.0% and 0.62% for MapCHECK. The statistical analysis between the overall values obtained from measurements of two detector systems in terms of mean , percentage of points with <1 and <1.5, respectively were in strong agreement with each other.
